摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-methylacridin-9-yl)-[3-(9-{3-(2-methylacridin-9-ylamino)-propyl}-2,4,8,10-tetraoxa-spiro[5,5]undec-3-yl)-propyl]-amine

中文名称
——
中文别名
——
英文名称
(2-methylacridin-9-yl)-[3-(9-{3-(2-methylacridin-9-ylamino)-propyl}-2,4,8,10-tetraoxa-spiro[5,5]undec-3-yl)-propyl]-amine
英文别名
(2-Methyl-acridin-9-yl)-[3-(9-{3-[(2-methylacridin-9-ylamino)]-propyl}-2,4,8,10-tetraoxa-spiro[5,5]undec-3-yl)-propyl]-amine;2-methyl-N-[3-[3-[3-[(2-methylacridin-9-yl)amino]propyl]-2,4,8,10-tetraoxaspiro[5.5]undecan-9-yl]propyl]acridin-9-amine
(2-methylacridin-9-yl)-[3-(9-{3-(2-methylacridin-9-ylamino)-propyl}-2,4,8,10-tetraoxa-spiro[5,5]undec-3-yl)-propyl]-amine化学式
CAS
——
化学式
C41H44N4O4
mdl
——
分子量
656.825
InChiKey
ATSGZEVTOMDNMQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.4
  • 重原子数:
    49
  • 可旋转键数:
    10
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    86.8
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    9-氯-2-甲基吖啶3,9-双(3-氨丙基)-2,4,8,10-四氧杂螺[5.5]十一烷甲醇 为溶剂, 反应 17.0h, 以43%的产率得到(2-methylacridin-9-yl)-[3-(9-{3-(2-methylacridin-9-ylamino)-propyl}-2,4,8,10-tetraoxa-spiro[5,5]undec-3-yl)-propyl]-amine
    参考文献:
    名称:
    Synthesis of Bis-acridine Derivatives Exhibiting Anticancer and Anti-inflammatory Activity
    摘要:
    A series of bis‐acridine derivatives 3aj and 5aj have been synthesized by condensation of 9‐chloro‐2,4‐(un)substituted acridines (1ae) and 9‐isothiocyanato‐2,4‐(un)substituted acridines (4ae) with diamine 2a and 2b, respectively. These bis‐acridines were evaluated in vitro for activity against a panel of human cancer cell lines of lung (NCI H‐522), ovary (PA1), breast (T47D), colon (HCT‐15), and liver (HepG2). Several bis‐acridines were found to possess good anticancer activity against various cancer cell lines. Of these, compound 3h exhibited good anticancer activity against all cancer cell lines tested except liver (HepG2) cell line. In addition to this, these compounds were screened for anti‐inflammatory activity at a dose of 50 mg/kg p.o. Compound 3g exhibited 41% anti‐inflammatory activity, which is better than most commonly used standard drug ibuprofen, which showed 39% anti‐inflammatory (at 50 mg/kg p. o.) activity.
    DOI:
    10.1002/jhet.985
点击查看最新优质反应信息

文献信息

  • Synthesis of Bis-acridine Derivatives Exhibiting Anticancer and Anti-inflammatory Activity
    作者:Sham M. Sondhi、Sandeep Kumar、Reshma Rani、Ajanta Chakraborty、Partha Roy
    DOI:10.1002/jhet.985
    日期:2013.3
    A series of bis‐acridine derivatives 3aj and 5aj have been synthesized by condensation of 9‐chloro‐2,4‐(un)substituted acridines (1ae) and 9‐isothiocyanato‐2,4‐(un)substituted acridines (4ae) with diamine 2a and 2b, respectively. These bis‐acridines were evaluated in vitro for activity against a panel of human cancer cell lines of lung (NCI H‐522), ovary (PA1), breast (T47D), colon (HCT‐15), and liver (HepG2). Several bis‐acridines were found to possess good anticancer activity against various cancer cell lines. Of these, compound 3h exhibited good anticancer activity against all cancer cell lines tested except liver (HepG2) cell line. In addition to this, these compounds were screened for anti‐inflammatory activity at a dose of 50 mg/kg p.o. Compound 3g exhibited 41% anti‐inflammatory activity, which is better than most commonly used standard drug ibuprofen, which showed 39% anti‐inflammatory (at 50 mg/kg p. o.) activity.
查看更多